Investigators assessed the etiology, clinical implications, and long-term outcomes of fatty pancreas.
Experts conclude this series highlighting what is on the horizon of retinal disease care.
Ted Lain, MD, reviews available support groups, vitiligo education, and other resources for patients with the disease.
Closing their discussion on insomnia, panelists share final thoughts and advice for community physicians.
The results found those with sexual minority status were significantly more likely to attend prenatal care visits (20%) when compared with heterosexual women.
Mamta Jain, MD, MPH, summarizes community outreach efforts regarding the training and education of health workers.
Retina specialists share advice and practice pearls regarding the management of DME and neovascular AMD, including counseling patients about the importance of healthy lifestyles.
Concluding their discussion on sickle cell disease management, expert panelists share key unmet needs and hopes for the future.
Drs C. Michael Gibson, Ashgan A. Elshinawy, and Nathaniel F. Watson share resources for the treatment of sleep disorders.
At the Family Heart Global Summit 2024, Bhatia spoke about the importance of universal Lp(a) screening over only targeted screening.
Panelists discuss how their approaches to treating patients with rheumatoid arthritis focus on personalized strategies that prioritize achieving remission while carefully monitoring safety and efficacy outcomes.
Atopic dermatitis, AD, JAK inhibitors, AD treatment, atopic dermatitis treatment, long-term safety, safety, herpes zoster
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
Fran Cogen, MD, joins Diana Isaacs, PharmD, BCPS, BC-ADM, CDCES, and Natalie Bellini, DNP, FNP-BC, on this MEDcast episode to stress the significance of early detection for type 1 diabetes. The conversation covers screening protocols and options, as well as emerging treatments that can delay the onset of the disease.
Atopic dermatitis, AD, JAK inhibitors, AD treatment, atopic dermatitis treatment, long-term safety, safety, herpes zoster
Ana-Maria Orbai, MD, MHS, leads the discussion on a real-world case scenario of a 57-year-old man who presents with severe plaque psoriasis and arthritis and shares clinical impressions as well as therapeutic goals for the patient.
Clinical pearls regarding the management of patients with atopic dermatitis with newer treatment approaches as the field continues to evolve.
People living with HP generally experience a profound lack of knowledge about their disease, driving poorer health-related quality of life. A study sought to create educational resources to curb this effect.
Moritz Pettenkofer, MD, presents a case of a 75-year-old male patient with nARMD who has had 53 injections of anti-VEGF therapy over 4 years.
A panel of expert cardiologists share their concluding thoughts on management of polyvascular disease in clinical practice.
Experts in hepatology review the unmet needs in primary biliary cholangitis, commenting on liver transplant, ethnic disparities, management of pruritis, as well as other symptoms.
Sophie M. Lanzkron, MD, MHS; Jeffrey D. Lebensburger; and John J. Strouse, MD, PhD, share key takeaways and closing thoughts for the management of sickle cell disease.
Jessica Allegretti, MD, MPH, and Edward Loftus Jr., MD, review emerging agents in the later phases for the management of IBD.
The panel offers their final recommendations for physicians managing patients with asthma.